A quality complaint investigation was performed.Six individual nebulizers with six labels of product 3773mm, and lot number 105415 were received on may 18, 2015.Labels were attached to initial complaint form dated on 04/28/2015.Returned nebulizers are the nebulizer of product 3773mm.Samples were tested to measure the aerosol output (aerosol steam get out) as per specification.Nebulizers generate the aerosol steam, but all samples did not meet 1.5 mg.Aerosol output requirements when operated.Samples marked as 1 and 3 did not meet the minimum aerosol output requirement.Samples were visually inspected to identify any visual characteristics that are not according to specification.The only observed characteristic was the orifice of nebulizer bottom not completely circular and there is a very small flash around the orifice.Orifice of nebulizer cup was measured and all samples met dimensions specified as in the current specification.The product (nebulizer) generates aerosol steam as it should, but the amount of aerosol output is not according to specification when operated at the lower flow rate (6 1/min).Additionally, two samples failed to meet requirement when operated at higher flow rate (10 1/min).Investigation performed by quality department of the manufacturing site indicated that product failed to meet the minimum aerosol output (1.5 ml) requirement specified in convatec test procedure.No previous investigations are available to leverage.After review of the returned product and detailed batch review, a discrepancy (minimum aerosol output below specification) was found.This warrants further action and a non-conformance will be opened.The complaint will remain in open status until completion of the corrective/preventive action.There are five (5) cases associated with this product; therefore a separate fda form 3500a has been generated to address the other four (4) cases.This is record 4 of 5 to capture the reported issue of does not produce an aerosol steam.No additional patient/event details have been provided to date.Should additional information become available a follow-up report will be submitted.Reported to the fda on june 01, 2015.
|